Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa

Gut

Volumn 48, Issue 6, 2001, Pages 792-796

  Pera, M ^a   Heppell, J ^a   Poulsom, R ^b   Teixeira, F V ^a   Williams, J ^a  

^a MAYO CLINIC   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chronic ulceration; Pouchitis; Trefoil peptides; Ulcer associated cell lineage

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; TREFOIL PEPTIDE;

ANASTOMOSIS; ARTICLE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM ULCER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEITIS; ILEUM MUCOSA; ILEUM POUCH; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AUTORADIOGRAPHY; BIOPSY; CASE-CONTROL STUDIES; CELL LINEAGE; CHRONIC DISEASE; HUMANS; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; PEPTIC ULCER; PEPTIDES; POUCHITIS; RNA, MESSENGER;

EID: 0035010938     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.6.792     Document Type: Article

References (36)

1. 1 Pemberton JH, Kelly KA, Beart RW, et al. Ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 1987;206:504-13.
2. 2 Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal reservoir. Int J Colorectal Dis 1986; 1:167-74.
3. 3 Shepherd NA, Jass R, Duval Y. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40:601-7.
4. 4 de Silva HJ, Millard PR, Kettlewell M. Mucosal characteristics of pelvic ileal pouches. Gut 1991;32:61-5.
5. 5 Setti Carraro P, Talbot IC, Nicholls RJ. Long term appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis. Gut 1994;35:1721-7.
6. 6 Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
7. 7 Heppell J, Kelly KA. Pouchitis. Curr Opin Gastroenterol 1998;14:2-8
8. 8 Thompson-Fawcet MW, Jewell DP, Morrensen JM. Ileoanal reservoir dysfunction: a problem-solving approach. Br J Surg 1997;84:1351-9.
9. 9 de Silva HJ, Millard PR, Soper N, et al. Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut 1991;32: 1166-9.
10. 10 Hanby AM, Wright NA. The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol 1993;171:3-4.
11. 11 Liber AF. Aberrant pyloric glands in regional ileitis. Arch Pathol 1951;51:205-12.
12. 12 Hanby A, Jankowski J, Elia G, et al. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native esophageal epithelium; delineation of a epithelial phenotype. J Pathol 1994;173: 213-19.
13. 13 Wright N, Poulsom R, Stamp G. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged gastrointestinal tissues. J Pathol 1990;162:279-84.
14. 14 Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor secreting lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82-5.
15. 15 Wright N, Hoffman W, Otto W, et al. Rolling in the clover-trefoil factor (TFF) domain peptides, cell-migration and cancers. FEBS Letters 1997;408:121-3.
16. 16 Dignass A, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming growth factor-βindependent pathway. J Clin Invest 1994; 94:376-83.
17. 17 Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci 1997;53:888-903.
18. 18 Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-9.
19. 19 Sandborn WJ, Tremaine WJ, Batts KP. Pouchitis after ileal pouch-anal anastomosis: A pouchitis activity index. Mayo Clin Proc 1994;69:409-15.
20. 20 Hanby AM, Poulsom R, Singh S, et al. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105:1110-16.
21. 21 Poulsom R, Hanby AM, Lalani EN, et al. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are co-expressed in normal hyperplastic and neoplastic human breast epithelium. J Pathol 1997;183:30-8.
22. 22 Poulsom R, Longcroft JM, Jeffery RE, et al. A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens. Eur J Histochem 1998;42:121-32.
23. 23 Zandvliet DWJ, Hanby AM, Austin CA, et al. Analysis of foetal expression sites of human type II DNA topoisomerase α and β mRNAs by in situ hybridisation. Biochim Biophys Acta 1996;1307:239-47.
24. 24 Ahnen D, Poulsom R, Stamp G. The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentation programme but acquires the proliferative organization of the gastric gland. J Pathol 1994;173:317-26.
25. 25 Hanby AM, Pera M, Filipe I, et al. Duodenal content reflux esophagitis in the rat: An animal model for the ulcer-associated cell lineage (UACL)? Am J Pathol 1997;151: 1819-24.
26. 26 Poulsom R, Trefoil peptides. Baillieres Clin Gastroenterol Cytokines Growth Factors Gastroenterol 1996;10:113-34.
27. 27 Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
28. 28 Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
29. 29 Mashimo H, Wu DC, Podolsky D, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
30. 30 Kindon H, Pothoulakis C, Thim L, et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
31. 31 Babyatsky M, DeBeaumont M, Thim L, et al. Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology 1996;110: 489-97.
32. 32 Chinery R, Cox HM. Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br J Pharmacol 1995;115:77-80.
33. 33 Chinery R, Playford R. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 1995;88:401-3.
34. 34 Hauser F, Poulsom R, Chinery R, et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993;90:6961-5.
35. 35 Duclos B, Rio M-C, Reimund JM, Chamouard P, et al. Increased pS2 secretion in serum of Crohn's disease patients. Gastroenterology 1996;100;A520.
36. 36 Miyashita S, Nomoto H, Konishi H, et al. Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay. Clin Chim Acta 1994;228:71-81.